Immune-related myositis resulting from combination therapy of ipilimumab and nivolumab in patient with metastatic renal cell carcinoma.

导出 OA

翻译打印收藏纠错

作者： Naoya,Okubo ^[1] ; Toshiki,Kijima ^[2] ; Akinori,Nukui ^[1] ; Takao,Kamai ^[1]

作者单位： Department of Urology, Dokkyo Medical University, Shimotsuga, Tochigi, Japan. ^[1] Department of Urology, Dokkyo Medical University, Shimotsuga, Tochigi, Japan tkijima@dokkyomed.ac.jp. ^[2]

关键词 urinary and genital tract disorders urological cancer urological surgery

主题词骨肿瘤(Bone Neoplasms);癌, 肾细胞(Carcinoma, Renal Cell);诊断, 鉴别(Diagnosis, Differential);人类(Humans);免疫学试验(Immunologic Tests);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);肌炎(Myositis);肿瘤分期(Neoplasm Staging);肾切除术(Nephrectomy);病人医护管理(Patient Care Management);体层摄影术, X线计算机(Tomography, X-Ray Computed)

DOI 10.1136/bcr-2020-235199

PMID 32912886

发布时间 2022-09-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

BMJ case reports

2020年13卷9期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Immune-related myositis resulting from combination therapy of ipilimumab and nivolumab in patient with metastatic renal cell carcinoma.

BMJ case reports

相似文献

BMJ case reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Immune-related myositis resulting from combination therapy of ipilimumab and nivolumab in patient with metastatic renal cell carcinoma.

BMJ case reports

相似文献

BMJ case reports

相关期刊

检索历史清除